Serology III Positive Control is intended for use with in vitro assays for deter
Serology III Positive Control is intended for use with in vitro assays for determination of IgM antibodies to Hepatitis B Core Antigen (HBc IgM) and IgM antibodies to Hepatitis A (HAV IgM). Serology III Positive Control is unassayed without target values and is suitable for use on many analysers. These controls must not be used as a substitute for the mandatory manufacturer’s kit controls provided with the assay.Serology III Positive Control is helpful in determining the precision of testing systems and in identifying sources of variation.
SEROLOGY III POSITIVE CONTROL (SEROLOGY III CONTROL +)
Serology II Positive Control is intended for use with in vitro assays for determ
Serology II Positive Control is intended for use with in vitro assays for determination of antibodies to Hepatitis B Surface Antigen (Anti HBs), IgG antibodies to Hepatitis B Core Antibodies (Anti HBc), antibodies to Hepatitis A (Anti HAV) and antibodies to Hepatitis B Envelope (Anti HBe). Serology II Positive Control is unassayed without target values and is suitable for use on many analysers. These controls must not be used as a substitute for the mandatory manufacturer’s kit controls provided with the assay.Serology II Positive Control is helpful in determining the precision of testing systems and in identifying sources of variation.
SEROLOGY II POSITIVE CONTROL (SEROLOGY II CONTROL +)
Serology I Postive Control is intended for use with in vitro assays for determin
Serology I Postive Control is intended for use with in vitro assays for determination of antibodies to Human Immunodeficiency Virus Type 1 and 2 (HIV-1/2), antibodies to Human T-Lymphotropic Virus Type 1 and 2 (HTLV-1/2), antibodies to Hepatitis C Virus (HCV), Hepatitis B Surface Antigen (HBsAg), IgG antibodies to Hepatitis B Core Antibodies (HBc) and IgG antibodies to Treponema pallidum. Serology I Positive Control is unassayed without target values and is suitable for use on many analysers. These controls must not be used as a substitute for the mandatory manufacturer’s kit controls provided with the assay.Serology I Positive Control is helpful in determining the precision of testing systems and in identifying sources of variation.
SEROLOGY I POSITIVE CONTROL (SEROLOGY I CONTROL +)
Serology Negative Control is intended for use as an unassayed non-reactive quali
Serology Negative Control is intended for use as an unassayed non-reactive quality assurance reagent with in vitro assays detecting antibody to Human Immunodeficiency Virus Type 1/2 (anti-HIV-1/2), antibody to Human T-Lymphotropic Virus Type I/II (anti-HTLV-I/II), Human Immunodeficiency Virus P24 Antigen (HIV P24 Ag), antibody to Hepatitis C Virus (anti-HCV), Immunoglobulin M and total antibodies to Hepatitis B core Antigen (HBc-IgM and anti-HBc Total), Hepatitis B Surface Antigen (HBsAg), antibody to Hepatitis B Surface Antigen (anti-HBs), Immunoglobulin M and total antibody to Hepatitis A Virus (HAV-IgM and anti-HAV Total), Hepatitis B Envelope Antigen (HBeAg), antibody to Hepatitis B Envelope Antigen (anti-HBe) and antibodies to Treponema pallidum.Serology Negative Control is unassayed without target values and is suitable for use on many analysers. These controls must not be used as a substitute for the mandatory manufacturer’s kit controls provided with the assay.Serology Negative Control is helpful in determining the precision of testing systems and in identifying sources of variation.
ToRCH EBV Positive Control is intended for use with in vitro assays for determin
ToRCH EBV Positive Control is intended for use with in vitro assays for determination of IgG and IgM antibodies to the viral capsid antigen of Epstein-Barr Virus (EBV VCA) and IgG antibodies to the viral polypeptide nuclear antigen of Epstein-Barr Virus (EBV EBNA).ToRCH EBV Positive Control is unassayed without target values and is suitable for use on many analysers. This control must not be used as a substitute for the mandatory manufacturer’s kit controls provided with the assay.ToRCH EBV Positive Control is helpful in determining the precision of testing systems and in identifying sources of variation.
SEROLOGY ToRCH EBV POSITIVE CONTROL (ToRCH EBV CONTROL +)
ToRCH IgM Positive Control is intended for use with in vitro assays for determin
ToRCH IgM Positive Control is intended for use with in vitro assays for determination of IgM antibodies to Cytomegalovirus (CMV), IgM antibodies to Rubella Virus, IgM antibodies to Toxoplasma gondii, IgM antibodies to Herpes Simplex Virus Type 1 and 2.ToRCH IgM Positive Control is unassayed without target values and is suitable for use on many analysers. This control must not be used as a substitute for the mandatory manufacturer’s kit controls provided with the assay.ToRCH IgM Positive Control is helpful in determining the precision of testing systems and in identifying sources of variation.
SEROLOGY ToRCH IgM POSITIVE CONTROL (ToRCH IgM CONTROL +)
ToRCH IgG Positive Control is intended for use with in vitro assays for determin
ToRCH IgG Positive Control is intended for use with in vitro assays for determination of IgG antibodies to Cytomegalovirus (CMV), IgG antibodies to Rubella Virus, IgG antibodies to Toxoplasma gondii, IgG antibodies to Herpes Simplex Virus Type 1 and 2, IgG antibodies to Mumps Virus, IgG antibodies to Measles Virus, IgG antibodies to Varicella Zoster Virus, IgG antibodies to Helicobacter pylori IgG antibodies to Treponema pallidum (Syphilis), IgG antibodies to the viral polypeptide nuclear antigen of Epstein-Barr Virus (EBV EBNA). ToRCH IgG Positive Control is unassayed without target values and is suitable for use on many analysers. This control must not be used as a substitute for the mandatory manufacturer’s kit controls provided with the assay.ToRCH IgG Positive Control is helpful in determining the precision of testing systems and in identifying sources of variation.
SEROLOGY ToRCH IgG POSITIVE CONTROL (ToRCH IgG CONTROL +)
ToRCH Negative Control is intended for use as an unassayed non-reactive quality
ToRCH Negative Control is intended for use as an unassayed non-reactive quality assurance reagent with in vitro assays detecting IgG and IgM antibodies to Cytomegalovirus (CMV), IgG and IgM antibodies to Rubella virus, IgG and IgM antibodies to Toxoplasma gondii, IgG and IgM antibodies to Herpes Simplex Type 1 and 2, IgG antibodies to Mumps Virus, IgG antibodies to Rubeola Virus (Measles), IgG antibodies to Varicella Zoster Virus, IgG antibodies to Helicobacter pylori, IgG antibodies to Treponema pallidum (Syphilis), IgG and IgM antibodies to the Viral Capsid Antigen of Epstein-Barr virus (EBV VCA) and IgG antibodies to the Viral Polypeptide Nuclear Antigen of Epstein-Barr Virus (EBV EBNA IgG).
Liquichek Netherlands Unassayed Chemistry Plus Control Level 3 ( A human serum c
Liquichek Netherlands Unassayed Chemistry Plus Control Level 3 ( A human serum chemistry and protein control.)
Liquichek Netherlands Unassayed Chemistry Plus Control Level 2 ( A human serum c
Liquichek Netherlands Unassayed Chemistry Plus Control Level 2 ( A human serum chemistry and protein control.)
Liquichek Netherlands Unassayed Chemistry Plus Control Level 1 ( A human serum c
Liquichek Netherlands Unassayed Chemistry Plus Control Level 1 ( A human serum chemistry and protein control.)
Automated test for use on the VIDAS® system to detect abnormal operation of the
Automated test for use on the VIDAS® system to detect abnormal operation of the VIDAS and mini VIDAS instrument pipette mechanisms and optical systems.
NATtrol™ Vaginal Bundle contains qualitative in vitro diagnostic controls, NATtr
NATtrol™ Vaginal Bundle contains qualitative in vitro diagnostic controls, NATtrol Vaginal Positive Control (NATVPOS-6C) DI number 01220000260290, and NATtrol Vaginal Negative Control (NATVNEG-6C) DI number 01220000260306, which are intended to be used with molecular assays for the detection of Atopobium vaginae, BVAB2, Candida albicans, Candida glabrata, and Trichomonas vaginalis for the evaluation of test performance.
NATtrol™ Vaginal Negative Control (NATVNEG-6C) is a qualitative in vitro diagnos
NATtrol™ Vaginal Negative Control (NATVNEG-6C) is a qualitative in vitro diagnostic control intended to be used with molecular assays for the detection of Atopobium vaginae, BVAB2, Candida albicans, Candida glabrata, and Trichomonas vaginalis for the evaluation of test performance.
NATtrol™ Vaginal Positive Control (NATVPOS-6C) is a qualitative in vitro diagnos
NATtrol™ Vaginal Positive Control (NATVPOS-6C) is a qualitative in vitro diagnostic control intended to be used with molecular assays for the detection of Atopobium vaginae, BVAB2, Candida albicans, Candida glabrata, and Trichomonas vaginalis for the evaluation of test performance.
NATtrol™ Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Negative Control
NATCTNGNEG-6MC
NATCTNGNEG-6MC is a qualitative in vitro diagnostic external run control intende
NATCTNGNEG-6MC is a qualitative in vitro diagnostic external run control intended to be used with molecular assays.
NATtrol™ Neisseria gonorrhoeae (NG) Positive Control
NATNG-6MC
NATNG-6MC is a qualitative in vitro diagnostic external run control intended to
NATNG-6MC is a qualitative in vitro diagnostic external run control intended to be used with molecular assays.
NATtrol™ Chlamydia trachomatis (CT) Positive Control
NATCT(434)-6MC
NATCT(434)-6MC is a qualitative in vitro diagnostic external run control intende
NATCT(434)-6MC is a qualitative in vitro diagnostic external run control intended to be used with molecular assays.
The NATtrol™ Staphylococcus aureus (SA) Positive Control is an unassayed in vitr
The NATtrol™ Staphylococcus aureus (SA) Positive Control is an unassayed in vitro diagnostic external run control intended to be used with qualitative molecular assays for detection of nucleic acids from this organism. The control is intended to be used as an aid to diagnosis in that it is used to verify performance of the assays used to detect a physiological or pathological state. The routine and repetitive use of external run controls enables laboratories to monitor daily test variation, lot-to-lot test kit performance, individual operator variation, and can provide assistance in identifying increases in random or systemic errors. NATtrol™ SA Positive Control contains intact organisms and should be run in a manner identical to that used for clinical specimens. The control does not have an assigned value and it is the responsibility of the end user to establish their own target specifications for the control using their laboratory’s molecular procedures.
The Methicillin-Resistant Staphylococcus aureus/Staphylococcus aureus (MRSA/SA)
The Methicillin-Resistant Staphylococcus aureus/Staphylococcus aureus (MRSA/SA) Negative Control is an unassayed in vitro diagnostic external run control intended to be used with qualitative molecular assays for detection of nucleic acids from these organisms. The control is intended to be used as an aid to diagnosis in that it is used to verify performance of the assays used to detect a physiological or pathological state. The routine and repetitive use of external run controls enables laboratories to monitor daily test variation, lot-to-lot test kit performance, individual operator variation, and can provide assistance in identifying increases in random or systemic errors. NATtrol™ MRSA/SA Negative Control contains intact organisms and should be run in a manner identical to that used for clinical specimens. The control does not have an assigned value and it is the responsibility of the end user to establish their own target specifications for the control using their laboratory’s molecular procedures.
NATtrol™ Methicillin-Resistant Staphylococcus aureus Positive Control
NATMRSA-6MC-IVD
The NATtrol™ Methicillin-Resistant Staphylococcus aureus (MRSA) Positive Control
The NATtrol™ Methicillin-Resistant Staphylococcus aureus (MRSA) Positive Control is an unassayed in vitro diagnostic external run control intended to be used with qualitative molecular assays for detection of nucleic acids from this organism. The control is intended to be used as an aid to diagnosis in that it is used to verify performance of the assays used to detect a physiological or pathological state. The routine and repetitive use of external run controls enables laboratories to monitor daily test variation, lot-to-lot test kit performance, individual operator variation, and can provide assistance in identifying increases in random or systemic errors. NATtrol™ MRSA Positive Control contains intact organisms and should be run in a manner identical to that used for clinical specimens. The control does not have an assigned value and it is the responsibility of the end user to establish their own target specifications for the control using their laboratory’s molecular procedures.
The NATtrol™ Trichomonas vaginalis (T. vaginalis) Negative Control is an unassay
The NATtrol™ Trichomonas vaginalis (T. vaginalis) Negative Control is an unassayed in vitro diagnostic external run control intended to be used with qualitative molecular assays for detection of nucleic acids from these organisms. The control is intended to be used as an aid to diagnosis in that it is used to verify performance of the assays used to detect a physiological or pathological state. The routine and repetitive use of external run controls enables laboratories to monitor daily test variation, lot-to-lot test kit performance, individual operator variation, and can provide assistance in identifying increases in random or systemic errors. NATtrol™ T. vaginalis Negative Control contains intact organisms and should be run in a manner identical to that used for clinical specimens. The control does not have an assigned value and it is the responsibility of the end user to establish their own target specifications for the control using their laboratory’s molecular procedures.